These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7509384)

  • 1. After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.
    Feuer EJ; Frey CM; Brawley OW; Nayfield SG; Cunningham JB; Geller NL; Bosl GJ; Kramer BS
    J Clin Oncol; 1994 Feb; 12(2):368-77. PubMed ID: 7509384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of chemotherapy in patients with disseminated testicular tumors].
    Abdyldaev TA; Tiuliandin SA; Batov SV
    Vopr Onkol; 1990; 36(1):85-9. PubMed ID: 1689527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for favorable outcome in disseminated germ cell tumors.
    Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
    J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: the Memorial Sloan-Kettering Cancer Center experience (1975 to 1982).
    Israel A; Bosl GJ; Golbey RB; Whitmore W; Martini N
    J Clin Oncol; 1985 Aug; 3(8):1073-8. PubMed ID: 2410574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
    Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
    Raghavan D; Levi J; Thomson D; Harvey V
    Prog Clin Biol Res; 1990; 350():319-29. PubMed ID: 1696742
    [No Abstract]   [Full Text] [Related]  

  • 8. A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
    Fizazi K; Do KA; Wang X; Finn L; Logothetis CJ; Amato RJ
    Ann Oncol; 2002 Jan; 13(1):125-34. PubMed ID: 11863094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
    Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
    J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
    Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
    Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [VAB-6 chemotherapy of advanced testicular cancers--its efficacy and limitation].
    Takenaka A; Shimogaki H; Mizuno Y; Goto A; Goto K; Kawaida N; Gohji K; Ogawa T; Arakawa S; Matsumoto O
    Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1620-6. PubMed ID: 1722833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of chemotherapy in the treatment of testicular cancer with the exception of seminomas].
    Kenis Y; Piccart M; Beer M
    Rev Med Brux; 1983 Apr; 4(4):219-23. PubMed ID: 6192477
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term followup of 150 patients with testicular cancer treated at a single institution.
    Kantoff PW; Kalish LA; McDowell-Bryant P; Canellos GP; Gibbs R; Richie JP; Garnick MB
    J Urol; 1992 Jan; 147(1):82-8. PubMed ID: 1370332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 15. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
    Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
    Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of disseminated germ cell tumors of the testis].
    Tiuliandin SA
    Sov Med; 1987; (11):78-81. PubMed ID: 2451298
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of disseminated germ cell tumors.
    Einhorn LH
    Cancer; 1987 Aug; 60(3 Suppl):570-3. PubMed ID: 2439185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
    Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
    J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of testicular cancer: a new and improved model.
    Einhorn LH
    J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
    Grimison PS; Stockler MR; Thomson DB; Olver IN; Harvey VJ; Gebski VJ; Lewis CR; Levi JA; Boyer MJ; Gurney H; Craft P; Boland AL; Simes RJ; Toner GC
    J Natl Cancer Inst; 2010 Aug; 102(16):1253-62. PubMed ID: 20631341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.